XML 63 R51.htm IDEA: XBRL DOCUMENT v3.24.3
RESTRUCTURING CANADA OPERATIONS (Details)
$ in Millions
3 Months Ended 9 Months Ended
Mar. 28, 2024
USD ($)
Sep. 30, 2024
USD ($)
facility
Sep. 30, 2023
USD ($)
Sep. 30, 2024
USD ($)
facility
Sep. 30, 2023
USD ($)
Feb. 16, 2024
USD ($)
Feb. 16, 2024
CAD ($)
Feb. 15, 2024
USD ($)
Feb. 15, 2024
CAD ($)
Dec. 31, 2023
USD ($)
Restructuring                    
Number of pharmaceutical manufacturing facilities | facility   3   3            
Restructuring activity expense   $ 0 $ 0 $ 0 $ 1,132,000          
Assets held for sale   0   0           $ 8,020,000
Disposal Group, Held-for-Sale, Not Discontinued Operations | Oakville, Ontario Former Manufacturing Facility                    
Restructuring                    
Consideration $ 13,500,000         $ 14,200,000 $ 19.2 $ 14,200,000 $ 19.2  
Payment of commissions, taxes and other related costs 700,000                  
Gain on sale of property $ 5,300,000                  
Oakville, Ontario, Canada                    
Restructuring                    
Restructuring activity expense   0 $ 0 0 1,100,000          
Restructuring accrual   $ 0   $ 0            
Assets held for sale                   $ 8,000,000.0
Oakville, Ontario, Canada | Employee Severance                    
Restructuring                    
Restructuring activity expense         200,000          
Oakville, Ontario, Canada | Facility Closing                    
Restructuring                    
Restructuring activity expense         700,000          
Oakville, Ontario, Canada | Other Restructuring                    
Restructuring                    
Restructuring activity expense         $ 200,000